217 related articles for article (PubMed ID: 23815808)
1. Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.
Wu F; Ye X; Wang P; Jung K; Wu C; Douglas D; Kneteman N; Bigras G; Ma Y; Lai R
BMC Cancer; 2013 Jul; 13():317. PubMed ID: 23815808
[TBL] [Abstract][Full Text] [Related]
2. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.
Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R
Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620
[TBL] [Abstract][Full Text] [Related]
3. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells.
Ye X; Wu F; Wu C; Wang P; Jung K; Gopal K; Ma Y; Li L; Lai R
Cell Signal; 2014 Mar; 26(3):492-501. PubMed ID: 24291232
[TBL] [Abstract][Full Text] [Related]
5. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma.
Zhang J; Wang P; Wu F; Li M; Sharon D; Ingham RJ; Hitt M; McMullen TP; Lai R
Cell Signal; 2012 Apr; 24(4):852-8. PubMed ID: 22155737
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.
Su Q; Shen H; Gu B; Zhu N
Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000
[TBL] [Abstract][Full Text] [Related]
8. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
[TBL] [Abstract][Full Text] [Related]
9. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
[TBL] [Abstract][Full Text] [Related]
10. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
12. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
14. Twist1-Induced Epithelial Dissemination Requires Prkd1 Signaling.
Georgess D; Padmanaban V; Sirka OK; Coutinho K; Choi A; Frid G; Neumann NM; Inoue T; Ewald AJ
Cancer Res; 2020 Jan; 80(2):204-218. PubMed ID: 31676574
[TBL] [Abstract][Full Text] [Related]
15. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
16. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
17. TWIST1-WDR5-
Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
[TBL] [Abstract][Full Text] [Related]
18. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]